title: Incidence of catheter-related infections within 30 days from insertion of Hickman-Broviac catheters.
abstract: OBJECTIVE
  To evaluate the incidence of surgical site infections and bacteremias occurring within 30 days from insertion of partially implanted central venous catheters.
  
  
  METHODS
  Four hundred eighteen devices positioned in children with cancer or undergoing bone marrow transplant were followed prospectively.
  
  
  RESULTS
  During a follow-up of 12,394 catheter-days, a total of 13 infectious episodes were documented, with an overall incidence of 3.1% and 1.05 episodes/1,000 catheter-days. Coagulase-negative staphylococci represented the causative pathogens of all episodes. Overall, surgical wound infections occurred in 1.4% of all catheters, with a rate of 0.48/1,000 catheter-days, while isolated bacteremias were observed in 1.7% of all inserted devices, with a rate of 0.57/1,000 catheter-days.
  
  
  CONCLUSIONS
  Infections are rare events within 30 days from insertion of partially implanted central venous catheters and coagulase-negative staphylococci represent the most frequently isolated cause of these complications.
authors.affiliation: Department of Hematology and Oncology, Infectious Diseases Unit, G. Gaslini Children's Hospital, Genoa, Italy.
authors.forename: Elio
authors.initials: E
authors.lastname: Castagnola
authors.forename: Angelo Claudio
authors.initials: AC
authors.lastname: Molinari
authors.forename: Mareva
authors.initials: M
authors.lastname: Giacchino
authors.forename: Nadia
authors.initials: N
authors.lastname: Chiapello
authors.forename: Cristina
authors.initials: C
authors.lastname: Moroni
authors.forename: Ilaria
authors.initials: I
authors.lastname: Caviglia
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Fratino
authors.forename: Riccardo
authors.initials: R
authors.lastname: Haupt
mesh_terms: D016470:Bacteremia / Q000453:epidemiology* / Q000209:etiology; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002408:Catheters, Indwelling / Q000009:adverse effects; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D009369:Neoplasms / Q000150:complications / Q000453:epidemiology; D011446:Prospective Studies; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000209:etiology; D013997:Time Factors